Skip to content

Dr. Inge Vandenbempt

Active
Private limited companyfounded 20224 yrs activeMilsestraat 14, 3053 Oud-Heverlee, BelgiumKBO/BCE: BE 0782.664.096

The computed 12-month bankruptcy probability of Dr. Inge Vandenbempt is 2.7% (moderate). The 2024 annual accounts show equity of €158k and a net result of €56k. Equity is growing by ~47.9% per year across the filed fiscal years. The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.

Checked score

Score 2024
83 / 100
Excellent
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability100=
Solvency100▲+6
Growth52=
Track record94
Bankruptcy probability, 12 months
2.7% Moderate
0%0.5%1.5%4%10%≥ 25%
Credit up to €13k at 30 days acceptable
Liquidity ample (current ratio 5.02 against 2.83 in 2023; short-term debt: 18.3% and cash: 88.8% of total assets), and 18.6% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Four signals. The signal on the left, the evidence on the right.
+raises riskneutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 4 years 0 10 y
raises risk · No NACE activity registered
No NACE activity is registered in the KBO, which is more common among companies that later fail.
KBO · activities
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 29-09-2025, 60 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 3 filings
Deviation from the deadline
2025
not confirmed
2024
60 d late
2023
59 d late
2022
33 d early
← before the deadline after the deadline →
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2024, micro schema

Equity
€158k▲ 52.9%
2023 · €104k
2022: €59k 2023: €104k
2022 → 2024
Total assets
€194k▲ 28.8%
2023 · €151k
2022: €108k 2023: €151k
2022 → 2024
Net result
€56k▲ 4.6%
2023 · €54k
2022: €59k 2023: €54k
2022 → 2024
Working capital
€143k▲ 67.5%
2023 · €86k
2022: €33k 2023: €86k
2022 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line202220232024Trend
Equity€59k-€104k▲ 75.0%€158k▲ 52.9%
Operating result€75k-€67k▼ 10.4%€71k▲ 5.9%
Net result€59k-€54k▼ 8.5%€56k▲ 4.6%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€20k€40k€60k€80kOperating result 2022: €75k€75kNet result 2022: €59k€59kOperating result 2023: €67k€67kNet result 2023: €54k€54kOperating result 2024: €71k€71kNet result 2024: €56k€56k202220232024
The operating result recovers in 2024; 2024 is 6% above 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €194k
Fixed assets €16k▼ 17.0%
Current assets €179k▲ 35.3%
Equity and liabilities €194k
Equity €158k▲ 52.9%
Debt €36k▼ 23.8%
The debt ratio falls from 31.5% to 18.6%. Equity is higher and debt is lower.
Key figures and ratios
2024 value · change against 2023
EBITDA
€75k
2023 · €79k
Cash flow
€60k
2023 · €66k
Solvency
81.4%
2023 · 68.5%
Current ratio
5.02
2023 · 2.83
Quick ratio
5.02
2023 · 2.83
Debt / equity
0.23
2023 · 0.46
ROE
35.6%
2023 · 52.1%
ROA
29.0%
2023 · 35.7%
Interest coverage
125.62
2023 · 143.47
Debt
€36k
2023 · €48k
Debt ≤ 1 year
€36k
2023 · €47k
Income taxes
€15k
2023 · €13k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2024 against 2023
Balance sheet Code20232024
Assets
Total assets20/58€151k€194k
Fixed assets21/28€19k€16k
Intangible fixed assets21€16k€14k
Tangible fixed assets22/27€3k€1k
Plant, machinery and equipment23€270€759
Furniture and vehicles24€2k€503
Financial fixed assets28€660€660=
Current assets29/58€132k€179k
Amounts receivable within one year40/41€1k€3k
Trade receivables40€1k€3k
Cash at bank and in hand54/58€131k€173k
Deferred charges and accrued income490/1€365€3k
Equity and liabilities
Total equity and liabilities10/49€151k€194k
Equity10/15€104k€158k
Contributions10/11€1k€1k=
Profit (loss) carried forward14€103k€157k
Amounts payable17/49€48k€36k
Amounts payable within one year42/48€47k€36k
Trade debts44€4k€5k
Suppliers440/4€4k€5k
Taxes, remuneration and social security45€30k€16k
Taxes450/3€30k€16k
Other amounts payable47/48€12k€15k
Accrued charges and deferred income492/3€820€595
Income statement Code20232024
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€12k€4k
Other operating charges640/8€1k€1k
Gross operating margin9900€81k€76k
Operating profit (loss)9901€67k€71k
Financial income75/76B€265€777
Recurring financial income75€265€777
Financial charges65/66B€553€600
Recurring financial charges65€553€600
Profit (loss) for the period before taxes9903€67k€72k
Income taxes67/77€13k€15k
Profit (loss) for the period9904€54k€56k
Profit (loss) for the period to be appropriated9905€54k€56k
Appropriation of the result
Profit (loss) to be appropriated9906€112k€159k
Profit (loss) brought forward from the previous period14P€58k€103k
Profit to be distributed694/7€10k€2k
Return on contributions (dividend)694€2k€2k=
Directors or managers695€8k-

The notes to these accounts (9 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

2025
29-09
NBB filing Annual accounts filed
fiscal year 2024 · micro schema · 60 days late
2024
31-12
Financial Equity above €150kEq €158k ▲52.9%
3 profitable years in a row build equity to €158k.
28-09
NBB filing Annual accounts filed
fiscal year 2023 · micro schema · 59 days late
2023
31-12
Financial Weakest financial yearnet €54k ▼8.5%
Net result drops to €54k, the lowest in the series; recovery starts the following year.
31-12
Financial Equity above €100kEq €104k ▲75%
2 profitable years in a row build equity to €104k.
28-06
NBB filing Annual accounts filed
fiscal year 2022 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Oud-Heverlee · 1 establishment unit since 2022
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Milsestraat 143053 Oud-Heverlee
Ground area
1,237 m²
Building footprint
194 m²
Volume, LiDAR
1,020 m³
Parcel 24034C0071/00N004, Flanders · tallest building 10.2 m, ±1 floor. Linked by address, not a title deed.
1 establishment unit
Dr. Inge Vandenbempt
Milsestraat 14, 3053 Oud-HeverleeGeneral medical practice
since 20222.328.615.553
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
24034C0071/00N004 Flanders 1,237 m² 1 · 194 m² 10.2 m · 1 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded26-02-2022
Fiscal year end31-12
Sources
Crossroads Bank for EnterprisesNational Bank · 3 filingsAddress and cadastre registers

Data from official sources, last processed on 18-09-2026. Scores and ratios are computed by Checked and are not a credit decision.